A citation-based method for searching scientific literature

Bertrand Cariou, Zufeng Ding, Jawahar L Mehta. Atherosclerosis 2016
Times Cited: 13







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
61

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
Karin Leander, Anders Mälarstig, Ferdinand M Van't Hooft, Craig Hyde, Mai-Lis Hellénius, Jason S Troutt, Robert J Konrad, John Öhrvik, Anders Hamsten, Ulf de Faire. Circulation 2016
119
46

Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta.
Zufeng Ding, Shijie Liu, Xianwei Wang, Xiaoyan Deng, Yubo Fan, Changqing Sun, Yannian Wang, Jawahar L Mehta. Antioxid Redox Signal 2015
101
46

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
46

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.
Nicola Ferri, Gianpaolo Tibolla, Angela Pirillo, Francesco Cipollone, Andrea Mezzetti, Stefano Pacia, Alberto Corsini, Alberico Luigi Catapano. Atherosclerosis 2012
160
46

Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study.
Wuxiang Xie, Jing Liu, Wei Wang, Miao Wang, Yue Qi, Fan Zhao, Jiayi Sun, Jun Liu, Yan Li, Dong Zhao. Int J Cardiol 2016
46
38

Cross-talk between LOX-1 and PCSK9 in vascular tissues.
Zufeng Ding, Shijie Liu, Xianwei Wang, Xiaoyan Deng, Yubo Fan, Jiwani Shahanawaz, Robert J Shmookler Reis, Kattayi I Varughese, Tatsuya Sawamura, Jawahar L Mehta. Cardiovasc Res 2015
128
38

Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis.
Zufeng Ding, Shijie Liu, Xianwei Wang, Pankaj Mathur, Yao Dai, Sue Theus, Xiaoyan Deng, Yubo Fan, Jawahar L Mehta. Antioxid Redox Signal 2016
37
38

Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.
Da-Wei Zhang, Thomas A Lagace, Rita Garuti, Zhenze Zhao, Meghan McDonald, Jay D Horton, Jonathan C Cohen, Helen H Hobbs. J Biol Chem 2007
540
30

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.
Steve Poirier, Gaetan Mayer, Suzanne Benjannet, Eric Bergeron, Jadwiga Marcinkiewicz, Nasha Nassoury, Harald Mayer, Johannes Nimpf, Annik Prat, Nabil G Seidah. J Biol Chem 2008
306
30

PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement.
Nicola Ferri, Silvia Marchianò, Gianpaolo Tibolla, Roberta Baetta, Ashish Dhyani, Massimiliano Ruscica, Patrizia Uboldi, Alberico L Catapano, Alberto Corsini. Atherosclerosis 2016
58
30

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
Paul M Ridker, James Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto, Fernando Civeira, Marcus Flather, Robert J Glynn, Jean Gregoire, J Wouter Jukema,[...]. N Engl J Med 2017
374
30

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.
Nabil G Seidah, Suzanne Benjannet, Louise Wickham, Jadwiga Marcinkiewicz, Stephanie Belanger Jasmin, Stefano Stifani, Ajoy Basak, Annik Prat, Michel Chretien. Proc Natl Acad Sci U S A 2003
805
30

Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.
Geneviève Dubuc, Ann Chamberland, Hanny Wassef, Jean Davignon, Nabil G Seidah, Lise Bernier, Annik Prat. Arterioscler Thromb Vasc Biol 2004
455
23


Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular events.
Paul M Ridker, Nader Rifai, Gary Bradwin, Lynda Rose. Eur Heart J 2016
63
23

Clinical aspects of PCSK9.
Bertrand Cariou, Cédric Le May, Philippe Costet. Atherosclerosis 2011
113
23

PCSK9: a key modulator of cardiovascular health.
Nabil G Seidah, Zuhier Awan, Michel Chrétien, Majambu Mbikay. Circ Res 2014
359
23

PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
Jin M Cheng, Rohit M Oemrawsingh, Hector M Garcia-Garcia, Eric Boersma, Robert-Jan van Geuns, Patrick W Serruys, Isabella Kardys, K Martijn Akkerhuis. Atherosclerosis 2016
92
23

Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
Baris Gencer, Fabrizio Montecucco, David Nanchen, Federico Carbone, Roland Klingenberg, Nicolas Vuilleumier, Soheila Aghlmandi, Dik Heg, Lorenz Räber, Reto Auer,[...]. Eur Heart J 2016
96
23

Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention.
Yiming M Zhu, Todd J Anderson, Khokan Sikdar, Marinda Fung, Matthew J McQueen, Eva M Lonn, Subodh Verma. Arterioscler Thromb Vasc Biol 2015
55
23

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin.
Susan Kühnast, José W A van der Hoorn, Elsbet J Pieterman, Anita M van den Hoek, William J Sasiela, Viktoria Gusarova, Anusch Peyman, Hans-Ludwig Schäfer, Uwe Schwahn, J Wouter Jukema,[...]. J Lipid Res 2014
126
23

PCSK9 induces a pro-inflammatory response in macrophages.
Chiara Ricci, Massimiliano Ruscica, Marina Camera, Laura Rossetti, Chiara Macchi, Alessandra Colciago, Ilaria Zanotti, Maria Giovanna Lupo, Maria Pia Adorni, Arrigo F G Cicero,[...]. Sci Rep 2018
98
23

PCSK9 and Atherosclerosis - Lipids and Beyond.
Michael D Shapiro, Sergio Fazio. J Atheroscler Thromb 2017
40
23


PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway.
Chun-Yan Wu, Zhi-Han Tang, Lu Jiang, Xue-Fei Li, Zhi-Sheng Jiang, Lu-Shan Liu. Mol Cell Biochem 2012
119
23

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Zhi-Han Tang, Juan Peng, Zhong Ren, Jing Yang, Ting-Ting Li, Tao-Hua Li, Zuo Wang, Dang-Heng Wei, Lu-Shan Liu, Xi-Long Zheng,[...]. Atherosclerosis 2017
105
23


PCSK9 inhibition and inflammation: A narrative review.
Massimiliano Ruscica, Lale Tokgözoğlu, Alberto Corsini, Cesare R Sirtori. Atherosclerosis 2019
44
23

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
23

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
Eliano P Navarese, Michalina Kolodziejczak, Max-Paul Winter, Arman Alimohammadi, Irene M Lang, Antonino Buffon, Gregory Yh Lip, Jolanta M Siller-Matula. Int J Cardiol 2017
53
23

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol.
Suzanne Benjannet, David Rhainds, Rachid Essalmani, Janice Mayne, Louise Wickham, Weijun Jin, Marie-Claude Asselin, Josée Hamelin, Mathilde Varret, Delphine Allard,[...]. J Biol Chem 2004
452
23

PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages.
Zufeng Ding, Shijie Liu, Xianwei Wang, Sue Theus, Xiaoyan Deng, Yubo Fan, Sichang Zhou, Jawahar L Mehta. Cardiovasc Res 2018
43
23


Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.
Holly E Careskey, R Aleks Davis, William E Alborn, Jason S Troutt, Guoqing Cao, Robert J Konrad. J Lipid Res 2008
241
15


Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
15

Inflammation stimulates the expression of PCSK9.
Kenneth R Feingold, Arthur H Moser, Judy K Shigenaga, Sophie M Patzek, Carl Grunfeld. Biochem Biophys Res Commun 2008
152
15

Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis.
John H Boyd, Christopher D Fjell, James A Russell, Demetrios Sirounis, Mihai S Cirstea, Keith R Walley. J Innate Immun 2016
66
15

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Jennifer G Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S Stroes, Gisle Langslet, Frederick J Raal, Mahfouz El Shahawy,[...]. N Engl J Med 2015
15

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.
Marc S Sabatine, Robert P Giugliano, Stephen D Wiviott, Frederick J Raal, Dirk J Blom, Jennifer Robinson, Christie M Ballantyne, Ransi Somaratne, Jason Legg, Scott M Wasserman,[...]. N Engl J Med 2015
15

Unexpected roles for PCSK9 in lipid metabolism.
Anne K Soutar. Curr Opin Lipidol 2011
32
15

Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis.
Dhruva J Dwivedi, Peter M Grin, Momina Khan, Annik Prat, Ji Zhou, Alison E Fox-Robichaud, Nabil G Seidah, Patricia C Liaw. Shock 2016
71
15

PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells.
Emile Levy, Ali Ben Djoudi Ouadda, Schohraya Spahis, Alain Théophile Sane, Carole Garofalo, Émilie Grenier, Lea Emonnot, Sabrina Yara, Patrick Couture, Jean-François Beaulieu,[...]. Atherosclerosis 2013
100
15

Smooth muscle cell phenotypic switching in atherosclerosis.
Delphine Gomez, Gary K Owens. Cardiovasc Res 2012
497
15

PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia.
Sophie J Bernelot Moens, Annette E Neele, Jeffrey Kroon, Fleur M van der Valk, Jan Van den Bossche, Marten A Hoeksema, Renate M Hoogeveen, Johan G Schnitzler, Marie T Baccara-Dinet, Garen Manvelian,[...]. Eur Heart J 2017
96
15

PCSK9: A key factor modulating atherosclerosis.
Sha Li, Jian-Jun Li. J Atheroscler Thromb 2015
32
15

PCSK9 is a critical regulator of the innate immune response and septic shock outcome.
Keith R Walley, Katherine R Thain, James A Russell, Muredach P Reilly, Nuala J Meyer, Jane F Ferguson, Jason D Christie, Taka-aki Nakada, Chris D Fjell, Simone A Thair,[...]. Sci Transl Med 2014
211
15

Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Hagai Tavori, Ilaria Giunzioni, Irene M Predazzi, Deanna Plubell, Anna Shivinsky, Joshua Miles, Rachel M Devay, Hong Liang, Shirya Rashid, MacRae F Linton,[...]. Cardiovasc Res 2016
56
15

Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.
Maxime Denis, Jadwiga Marcinkiewicz, Ahmed Zaid, Dany Gauthier, Steve Poirier, Claude Lazure, Nabil G Seidah, Annik Prat. Circulation 2012
152
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.